Repligen Corp is a bioprocessing company developing, producing and commercializing biologic drugs. The company offers its products to life science companies, global biopharmaceutical companies, and contract manufacturers worldwide.
$212.54 -9.19 (-4.15%)
As of 03/02/2021 15:59:54 EST IEX book CBOE book
2021 © Stock Market MBA, Inc.